maternal-health
(25)
Sarah O'Leary
Sarah O'Leary is the CEO of Willow Innovations, the Mountain View company that built the first fully in-bra wearable breast pump. She joined Willow in 2019 as VP of Growth, climbed through CMO and Chief Commercial Officer roles, and was named CEO in December 2023. Under her, Willow moved from an e-commerce breakthrough to an omnichannel maternal-health brand, and in 2025 acquired UK femtech rival Elvie to build a scaled global platform. A mother of two who started her career in consulting, she is known for a 'mothers first' philosophy that treats the new mother as the person products should be built around.
Senan Ebrahim
Senan Ebrahim is the founder and CEO of Delfina, a San Francisco digital health company using AI and data science to improve pregnancy care and close gaps in maternal health. A physician-scientist with an MD and a PhD in computational neuroscience from Harvard, he founded Delfina after witnessing a preventable stillbirth during medical training. He earlier founded Hikma Health, a nonprofit building free health-data tools for refugee and low-income patients. Delfina raised a $17M Series A in early 2025 led by U.S. Venture Partners.
Adrianne Nickerson
Adrianne Nickerson is the co-founder and CEO of Oula, a New York maternity company that fuses midwives, OB-GYNs and technology into one hybrid clinic built to give pregnant patients a calmer, more personal, evidence-based birth experience. A Columbia biology grad with a Harvard master's in global health, she decided she could help patients more by not becoming a doctor - and instead builds the systems doctors and midwives work inside. She co-founded Oula in 2019, opened it while pregnant alongside two pregnant co-executives, and has raised tens of millions to expand care that reduces unnecessary C-sections and centers patient voices.
Delfina
Delfina is a San Francisco-based maternal health company that pairs an AI-powered clinical platform with a consumer pregnancy app to make prenatal care proactive rather than reactive. Its predictive models flag rising risk - preterm birth, hypertensive disorders, gestational diabetes - while patients track vitals from home and connect around the clock with bilingual virtual doulas, dietitians, and mental health support. Founded in 2021 by physician-scientist Dr. Senan Ebrahim and his co-founders, Delfina sells to health plans, providers, and employers, and has raised roughly $22M to date, including a $17M Series A in January 2025.
Lōvu Health
Lōvu Health is a Cupertino-based digital maternal health company that follows mother and baby from pre-conception through two years postpartum. It pairs connected home devices - a blood pressure monitor, smart scale and fetal Doppler - with a pregnancy navigator, an OB-facing dashboard, and a marketplace of 50+ specialty vendors, using real-time remote patient monitoring and AI to catch complications like preeclampsia and perinatal depression earlier.
Materna Medical
Materna Medical is a Mountain View, California women's health company building FDA-cleared medical devices for pelvic health across a woman's life. Its consumer product, Milli, is the first vaginal dilator that expands one millimeter at a time to treat vaginismus and painful intercourse; its clinical-stage Ellora obstetrical system is designed to pre-stretch pelvic floor muscles during labor to reduce childbirth injury. Led by CEO Tracy MacNeal, the company has raised roughly $82.6M to date.
Willow Innovations, Inc.
Willow Innovations is a U.S. femtech company that invented the first all-in-one, in-bra wearable breast pump, freeing new mothers from cords, tubes and the pumping room. Founded in 2014 out of Josh Makower's ExploraMed incubator, Willow now sells app-controlled, leak-proof pumps (Willow 360, Willow Go, Willow Sync and the manual Willow Wave) along with a growing line of feeding and postpartum accessories. In 2025 it acquired UK rival Elvie to build a scaled maternal-health platform.
Bloom Care
Bloom Care is a Brazilian femtech building the country's largest virtual clinic for women's and family health. Founded in 2017 by three women, its app pairs members with gynecologists, obstetricians, pediatricians, psychologists and nutritionists for continuous, evidence-based care across the full life journey - from menstrual health and fertility through pregnancy, postpartum, parenting and menopause. Sold mostly through employers and health plans on a B2B2C model, Bloom counts partners like Sanofi, SulAmérica, Natura and Nestlé, and was named to CB Insights' Digital Health 150.
Lilu, Inc.
Lilu is a New York femtech company building smart technology for new mothers. Its flagship Massage Bra is a hands-free wearable that uses patented pneumatic compression to mimic hand massage during pumping, helping mothers express more milk in less time, while its MilkSense app tracks feeding, pumping, and milk stash with AI-driven, personalized lactation insights. Founded by MIT- and Penn-trained engineers Adriana Vazquez and Sujay Suresh Kumar, Lilu aims to make postpartum care more comfortable, efficient, and pain-free.
Noora Health
Noora Health is a nonprofit that treats families as an untapped part of the care team. By training patients' relatives with practical, condition-specific health skills while they wait in hospital wards - then reinforcing that training after discharge through WhatsApp, voice calls, and live chat - its Care Companion Program has reached tens of millions of caregivers across India, Bangladesh, Indonesia, and Nepal, cutting newborn readmissions and post-surgical cardiac complications.
Neil Ray
Neil P. Ray, MD is a board-certified pediatric anesthesiologist who traded the operating room for a startup. As founder and CEO of Raydiant Oximetry, he is building Lumerah, a non-invasive fetal pulse oximeter that reads a baby's oxygen levels through the mother's abdomen, and Daisy, a surgical device to prevent postpartum hemorrhage. His goal: retire a 50-year-old fetal monitor he calls no better than a coin toss, and cut the number of unnecessary C-sections that follow from it.
Bloomlife
Bloomlife is a San Francisco maternal health company that pairs FDA-cleared wearable sensors with a connected-care platform so high-risk pregnancies can be monitored from home. Born from a co-founder's own NICU experience, the company shifts prenatal care out of the clinic and into the living room - tracking fetal heart rate, blood pressure and glucose, then feeding the data to clinicians through risk-stratification tools meant to catch complications earlier.
Mirvie
Mirvie is a South San Francisco biotech using cell-free RNA signatures and machine learning to predict pregnancy complications - preeclampsia, preterm birth, fetal growth restriction - months before symptoms appear. Its flagship product Encompass is a blood test built on a foundational study of nearly 11,000 pregnancies.
Amelia Degenkolb
Amelia Degenkolb is the CEO and co-founder of Novocuff, a Mountain View medical device company building the Cervical Control System, a device designed to stabilize the cervix, retain amniotic fluid and prolong pregnancies threatened by preterm premature rupture of membranes. A biomedical engineer who spent seven years as the first employee and lead engineer at Alydia Health, she helped bring the Jada System for postpartum hemorrhage to market before that company's $240M acquisition by Organon. In July 2024 she raised an oversubscribed $26M Series A to fund a U.S. pivotal trial aimed at reducing preterm births, the leading cause of infant mortality worldwide.
Maternova, Inc.
Maternova is a woman-owned, woman-run social enterprise based in Providence, Rhode Island that curates, evaluates, and distributes evidence-based medical devices and diagnostics for maternal, neonatal, and reproductive health in low- and middle-income countries. Founded in 2009 as the first e-commerce marketplace for global health technologies, it connects inventors and manufacturers who lack distribution with the governments, NGOs, hospitals, and clinicians who need life-saving tools - aggregating small orders to unlock manufacturing runs and accelerate access to innovations that prevent maternal and infant deaths.
Novocuff, Inc.
Novocuff, Inc. is a clinical-stage maternal health medical device company based in Mountain View, California, building the Novocuff Cervical Control System (CCS) - a device designed to stabilize and close the cervix, retain amniotic fluid, and extend pregnancy in cases of preterm prelabor rupture of membranes (PPROM) and cervical shortening. Founded in 2021 by Amelia Degenkolb and Donald Lee, the company raised an oversubscribed $26M Series A in 2024 (about $28M total) to fund its U.S. multicenter pivotal RETAIN trial, for which it secured FDA IDE approval in September 2025.
Sibel Health
Sibel Health is a Chicago-based digital health company spun out of Northwestern University that builds clinical-grade, fully wireless wearable sensors paired with AI analytics and a cloud platform. Its flagship ANNE One system continuously tracks vital signs - heart rate, respiratory rate, temperature, SpO2, pulse and more - for patients from neonates to adults, in hospitals, at home, and in low-resource settings around the world. The mission is to deliver 'Better Health Data for All.'
Maria Gabriela Salvador
Dr. M. Gabriela Salvador is the CEO of Maternova, Inc., a Providence-based global health company that runs an e-commerce marketplace for vetted, life-saving medical devices, diagnostics and nutrition products aimed at low- and middle-income countries. A physician trained as a pediatric ophthalmologist in Argentina, the United States and Mexico, she spent two decades building high-impact health programs at Americares, Grameen Foundation, Freedom from Hunger and Pro Mujer before taking the helm at Maternova in March 2023. Originally from Salta, Argentina, she pairs a medical degree from the National University of Cordoba with a Harvard MPH in health policy and management.
Raydiant Oximetry, Inc.
Raydiant Oximetry is a clinical-stage medical device company building Lumerah, a noninvasive, transabdominal fetal pulse oximeter that measures a baby's blood-oxygen levels during labor. By giving obstetricians a direct read on fetal oxygenation - rather than the coin-flip guesswork of conventional fetal heart-rate monitors - the company aims to cut unnecessary C-sections and reduce maternal and neonatal harm. It holds FDA Breakthrough Device designation and is partnered with GE HealthCare.
SimpliFed
SimpliFed is a virtual maternal health company based in Ithaca, New York, that helps families through pregnancy, postpartum, and baby feeding. Founded by biomedical engineer Andrea Ippolito in 2019, it began as insurance-covered virtual lactation support and has grown into a broader 'Maternal Health Operating System' (mOS) that pairs IBCLC lactation consultants and care navigators with prenatal and postpartum virtual OB services. Working in-network with most major commercial plans and Medicaid in multiple states, SimpliFed partners with health systems and OB clinics to extend judgment-free, evidence-based care into the home.
Steve Xu
Steve Xu is a board-certified dermatologist turned medtech founder who runs Sibel Health, the Chicago company commercializing ICU-grade wearable sensors that now monitor patients in more than 20 countries. A physician-engineer trained at Rice, Harvard, and the London School of Economics, he splits his life between the clinic, the lab at Northwestern's Querrey Simpson Institute for Bioelectronics, and a startup chasing a single line: Better Health Data for All.
Andrea Ippolito
Andrea Ippolito is the founder and CEO of SimpliFed, an Ithaca, New York company building a maternal health operating system that delivers virtual breastfeeding, infant nutrition and OB support to families in all 50 states at no cost through health plans. A biomedical engineer by training, she co-directed MIT Hacking Medicine, co-founded Smart Scheduling (acquired by athenahealth in 2016), served as a Presidential Innovation Fellow in the White House, and ran the VA's Innovators Network before turning her own postpartum struggle into a company that now partners with 300-plus health systems and raised an oversubscribed $10.8M Series A in 2026.
Genevieve Lemarchal
Genevieve Lemarchal is the Managing Partner of Suncoast Ventures and Head of Healthcare at Expert Dojo, one of Southern California's most active pre-seed venture funds. A serial entrepreneur turned investor, she focuses on early-stage healthcare startups tackling critical gaps in addiction recovery, maternal care, chronic disease management, and digital health. With a portfolio spanning 35+ companies across 7 countries, she champions underrepresented founders - 50% female, 37-43% from underrepresented backgrounds - and hosts the AdVentureous Podcast, where she interviews entrepreneurs and VCs about building companies that matter.
Eric Dy
Eric Dy, PhD is the co-founder and CEO of Bloomlife, a San Francisco-based women's health company building connected care solutions for maternal and fetal monitoring. A biomedical engineer by training (Cornell BSc, UCLA MSc and PhD), Dy spent four years at IMEC - Europe's leading R&D institute - establishing 17 partnerships worth $25M+ in revenue before launching Bloomlife in 2014. His personal experience watching his wife navigate a high-risk pregnancy - gestational diabetes, preeclampsia, placental complications, preterm labor, and a son who spent his first month in the NICU - drove him to attack the most underserved gap in American healthcare. Bloomlife's FDA-cleared MFM-Pro wearable lets high-risk pregnant patients be monitored at home, replacing the endless clinic visits that define the current broken system. The company raised a $12.2M Series A in September 2024 and has secured reimbursement across 18 payers.
Maneesh Jain
Maneesh Jain is the CEO and Co-founder of Mirvie, a South San Francisco-based biotech company pioneering RNA-based blood tests to predict pregnancy complications like preeclampsia and preterm birth months before symptoms occur. A serial entrepreneur with 20+ years in life sciences and more than $1.5B in combined exits across five prior startups - including Ion Torrent (acquired by Life Technologies) and Cirina (acquired by GRAIL) - Jain trained at the Stanford Genome Technology Center and holds a BS from Caltech and a Master's in Applied Physics from Stanford. Mirvie has raised over $90 million from investors including Khosla Ventures, GV, General Catalyst, and the Gates Foundation, and received FDA Breakthrough Device Designation for its preeclampsia risk test in 2022.